Combined Research Orlando Phase I-IV — Orlando, Florida

Combined Research Orlando Phase I-IV is a clinical research site located in Orlando, Florida, United States 32807.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Combined Research Orlando Phase I-IV has participated in 16 clinical trials with 4 currently active.

Therapeutic areas: Obsessive Compulsive Disorder, Depressive Disorder, Major, Early Alzheimer´s Disease.

Sponsors: Biohaven Pharmaceuticals, Inc., Naurex, Inc, an affiliate of Allergan plc, Novo Nordisk A/S.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Combined Research Orlando Phase I-IV?

Combined Research Orlando Phase I-IV has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Combined Research Orlando Phase I-IV conducted?

Combined Research Orlando Phase I-IV has 16 clinical trials on record, with 4 currently active. Their work covers Obsessive Compulsive Disorder, Depressive Disorder, Major, Early Alzheimer´s Disease.

Is Combined Research Orlando Phase I-IV accredited by Crixeo Health?

Yes — Combined Research Orlando Phase I-IV holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Combined Research Orlando Phase I-IV?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.